Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    63,991.49
    -821.92 (-1.27%)
     
  • CMC Crypto 200

    1,333.69
    -62.85 (-4.34%)
     
  • S&P 500

    5,105.23
    +56.81 (+1.13%)
     
  • Dow

    38,285.98
    +200.18 (+0.53%)
     
  • Nasdaq

    15,930.59
    +318.83 (+2.04%)
     
  • Gold

    2,350.80
    +8.30 (+0.35%)
     
  • Crude Oil

    83.88
    +0.31 (+0.37%)
     
  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

AstraZeneca’s 1Q18 Estimates: Segment-by-Segment Revenues

AstraZeneca’s 1Q18 Estimates: Segment-by-Segment Revenues

As we discussed in the previous article, AstraZeneca’s (AZN) revenue is expected to report a 2.3% fall to $5.3 billion in 1Q18 compared to $5.4 billion in 1Q17.